Pdl Biopharma Inc (PDLI)

EBITDA Growth

100.95%

Quarterly · Period ending:

PDLI logo

PDLI EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported100.95%
PDLI Quarterly EBITDA YoY % (97.14% → 100.95%)
High-resolution chart · PNG

PDLI ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
100.9476%
-1,527.8814%
-419.9514%
-250.0621%
-136.234%
100.7762%
11.8409%
-12.5979%
8.2535%
-193.5366%
-49.5581%
1,192.3434%
-5.0982%
1,013.3629%
-73.47%
-102.308%
-64.3874%
-91.832%
-34.2883%
69.0036%
-31.4268%
-4.2631%
2.9523%
-9.7102%
72.5618%
1.8293%
55.9137%
32.4077%
12.8458%
16.512%
25.0922%
21.456%
1.7011%
2.8595%
-9.2998%
352.5592%
9.6152%
23.8924%
47.9105%
-151.2589%
9.7316%
-21.7477%
-10.7976%
15.8499%
-0.7847%
170.4476%
223.5344%
1,263.1642%
346.2498%
23.207%
-871.9329%
105.0574%
-7.1947%
127.8467%
246.9557%
-193.1103%
178.5611%
-1.6187%
94.4704%
-131.5471%
-117.0427%
323.8095%
-893.6735%
85.2213%
23.8959%
81.7368%
-234.6774%
-1,427.666%
-188.1703%
-1,358.6751%
3.0905%
-162%
-330.7488%
-53.5463%
-45.1255%
-147.1294%
200.3197%
11.7772%
257.0467%
168.6471%
-270.6364%
439.1667%
382.4%
-24.3902%
-31.25%
25%
68.75%
73.2026%
1,700%
-20%
3.0303%
-1,430%
97.1429%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.